Combination ipilimumab/nivolumab for refractory Merkel cell carcinoma: A single-institution experience.

Authors: Mohammad Saad Farooq, Emily Ertmann, Gracia Vargas, Neha Shafique, Tara C. Mitchell, Lynn M. Schuchter, Ravi K. Amaravadi, Giorgos Constantine Karakousis, John Miura

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e21528

Source: Full article

---

Abstract

e21528